Cardiac Toxicity Completed Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005578Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's DiseaseTreatment